O reconhecimento eficiente do fungo Paracoccidioides brasiliensis pelos receptores do sistema imune inato do hospedeiro é essencial para a proteção contra a paracoccidioidomicose (PCM), micose sistêmica prevalente na América Latina. Diferente dos receptores do tipo Toll (TLRs),os receptores do tipo Nod-like (NLRs) são proteínas citoplasmáticas com capacidade de formar uma plataforma molecular denominada inflamassoma. Esta plataforma ativa caspase-1 e desencadeia a produção de IL-1? e IL-18. O inflamassoma de NLRC4 regula a resposta imune contra bactérias intracelulares através do reconhecimento de flagelina. No entanto, mesmo na ausência desta molécula, a bactéria Shigella flexneri é capaz de ativar o inflamassoma de NLRC4, o que sugere a existência de outros agonistas. Trabalhos recentes mostraram que o inflamassoma de NLRC4 tem papel importante no controle da infecção por Candida albicans. Contudo, sua participação na infecção por P. brasiliensis é uma incógnita. Portanto, o presente estudo teve como objetivo avaliar a participação do inflamassoma de NLRC4 na paracoccidioidomicose experimental. Os resultados obtidos demonstram que durante a infecção experimental por P. brasiliensis,macrófagos derivados de medula óssea (BMDM) provenientes de animais Nlrc4-/- produzem mais IL-1? do que BMDM de animais controles. Não foram detectadas diferenças significativas quanto aos níveis de TNF- ? em ambos os grupos. Para investigar o mecanismo responsável pelo aumento da produção de IL-1? por BMDM de camundongos Nlrc4-/-, as expressões do gene Nlrp3 e Nlrc4 foram avaliadas por qPCR durante, 0, 2, 6, 12, e 24 horas após a infecção. Comparado aos camundongos WT, BMDM de animais Nlrc4-/- exibiram um aumento na expressão de Nlrp3 durante as primeiras 12 horas de infecção. Surpreendentemente, 24 horas após a infecção, um aumento na expressão do gene de Nlrc4 foi detectado em BMDM de animais Nlrp3-/-, comparado ao controle. Estes resultados sugerem que o inflamassoma de NLRC4 reprime a atividade do inflamassoma de NLRP3, e consequentemente, anula a produção de IL-1? em macrófagos estimulados por P. brasiliensis. Além disso, camundongos Nlrc4-/- exibiram um aumento na produção de IL-1? e redução na produção de IL-18 aos7 dias após a infecção in vivo. Em contraste, a produção de IL-1? foi menor e a produção de IL-18 aumentou aos 30 dias após a infecção.Comparado ao grupo controle observamos menor carga fúngica, formação de granulomas bem definidos e compactos e redução na fibrose em pulmões de camundongos Nlrc4-/- aos 30 dias após infecção. Adicionalmente, observamos aumento na produção de citocinas do perfil Th1 (IFN-?, IL-12p40) e níveis reduzidos de IL-10. Em conclusão, estes dados mostram que o inflamassoma NLRC4 tem papel importante na suscetibilidade do hospedeiro durante a infecção por P. brasiliensis. / The efficient recognition of P. brasiliensis fungal cells by immune system receptors is essential for protection against paracoccidioidomycosis (PCM), a systemic mycosis prevalent in Latin America. Different from the Toll-like receptors (TLRs), NOD-like receptors (NLRs) are cytoplasmic proteins able to form the molecular platform, denominated inflammasome. This platform activates caspase-1 and triggers the production of IL-1? and IL-18. The NLRC4 inflammasome regulates the immune response against intracellular bacteria through recognition of flagellin. However, even in the absence of this structure, the bacteria Shigella flexneri activates the NLRC4 inflammasome, suggesting the existence of other agonists. It is known that NLRC4 control the Candida albicans infection. Therefore, in this study we evaluated the participation of NLRC4 inflammasome in experimental paracoccidioidomycosis. Our data demonstrated that Nlrc4-/- BMDMs produces more IL-1? than WT BMDMs during P. brasiliensis infection. No differences were detected regarding to TNF-? levels in both groups. To investigate the mechanism responsible to improvement of IL-1? production by Nlrc4-/- BMDMs, the nlrp3 and nlrc4 gene expression were evaluated by qPCR during 2, 6, 12 and 24 hours post infection. Compared to WT mice, the expression of nlrp3 was increased in Nlrc4-/- BMDMs during the first 12 hours of infection. Surprisingly, at 24 hour post infection and nlrc4 exhibited increased expression in Nlrp3-/- BMDMs, compared to WT controls. These data suggest that NLRC4 represses NLRP3 inflammasome activity, and consequently, abrogates the IL-1B production by P.brasiliensis estimuled macrophages. Furthermore, Nlrc4-/- mice exhibited an increased production of IL-1? and decreased production IL-18 at 7 days post infection in vivo. In contrast, there was a decrease in the production of IL-1? and increased production of IL-18 at 30 days post infection. Compared to controls, we observed lower fungal load, the formation of well-defined and compact lung granulomas, and decreased fibrosis in the lungs of Nlrc4-/- mice after 30 days post infection. In addition, we observed increased production of Th1 cytokine profile (IFN-?, IL-12p40) and reduced levels of IL-10. In conclusion, these data show that NLRC4 inflammasome play an important role on the host susceptibility during P. brasiliensis infection.

Activation of the NLRP3 inflammasome has been shown in response to numerous activators; here we show that the oxazolidinone antibiotic linezolid results in both the NLRP3-dependent in vitro release of the proinflammatory cytokine IL-1 Α; and in vivo neutrophilic influx following its intraperitoneal administration. Clinical use of linezolid is commonly limited by hematologic side effects; herein we also show NLRP3-deficiency protected animals against linezolid-induced effects on the bone marrow. Importantly, all previously described activators of the NLRP3 inflammasome have required the generation of reactive oxygen species (ROS). Linezolid is however unique amongst NLRP3 agonists in that its ability to activate the NLRP3 inflammasome in a ROS-independent manner. The pathways for ROS-dependent and ROS-independent NLRP3 activation converge upon mitochondrial dysfunction and specifically the mitochondrial lipid cardiolipin. We demonstrated that interference with cardiolipin synthesis specifically inhibits NLRP3 inflammasome activation. These findings firstly suggests that ROS generation is not the canonical activator of NLRP3 but rather an intermediary step leading to the mitochondrial perturbation that is tied to NLRP3 inflammasome activation and also implicate the involvement of mitochondrial lipid cardiolipin in this process; secondarily, linezolid-induced NLRP3 activation may account for thetoxicity associated with prolonged usage of this antibiotic.

京都大学 / 0048 / 新制・課程博士 / 博士(医学) / 甲第21626号 / 医博第4432号 / 新制||医||1033(附属図書館) / 京都大学大学院医学研究科医学専攻 / (主査)教授 高橋 淳, 教授 宮本 享, 教授 林 康紀 / 学位規則第4条第1項該当 / Doctor of Medical Science / Kyoto University / DFAM

京都大学 / 新制・課程博士 / 博士(医学) / 甲第24500号 / 医博第4942号 / 新制||医||1064(附属図書館) / 京都大学大学院医学研究科医学専攻 / (主査)教授 生田 宏一, 教授 萩原 正敏, 教授 渡邊 直樹 / 学位規則第4条第1項該当 / Doctor of Medical Science / Kyoto University / DFAM

Innate immunity has received impressive attention in the past decade owing to the discovery of the Toll like receptors (TLRs) and the NOD-like receptors (NLRs). While the TLRs specialize in fighting microbes at the cell surface, the NLRs complement by detecting and responding to intracellular microbes. Recently, the non-microbe sensing NLR called inflammasomes, have been identified, which senses metabolic stress as well as certain pathogenic microbes and elicits host’s inflammatory response. The NLR, NALP3 (formerly known as cryopyrin) forms a large cytoplasmic complex called the ‘inflammasome’ when NALP3, activated by a stimuli, associates with the adaptor proteins ASC and CARD-8. This interaction leads to the activation of pro-inflammatory caspase-1 which subsequently results in the formation of Interleukin (IL)-1β and IL-18. Mutations in the gene encoding NALP3, termed NLRP3 can lead to its constitutive activation resulting in an uncontrolled production of IL-1β. These mutations have been implicated in hereditary inflammatory diseases, often grouped under cryopyrin associated periodic syndromes (CAPS). This thesis describes a patient with a long history of arthritis and antibiotic resistant fever, but without the typical symptoms of CAPS. The patient was found to be a heterozygous carrier of two common polymorphisms Q705K in NLRP3 and C10X in the CARD-8. Experimental studies showed elevated levels of caspase-1 and IL-1β in the patient, and a total clinical remission was achieved by IL-1β blockade. These two polymorphisms combined, were found to occur in approximately 4% of the control population, suggesting the possibility of a genetic predisposition for inflammation in these individuals. Therefore, a cohort of rheumatoid arthritis (RA) patients, where elevated IL-1β could be one of the reasons behind chronic inflammation, was investigated. We found that carrying the combined polymorphisms resulted in increased RA susceptibility and a more severe disease course. Hypothetically, this subgroup of patients might benefit from IL-1β blockade. Additional studies are warranted to elucidate the functional effects of the two polymorphisms and to determine whether they identify a subgroup of patients that could benefit from IL-1 targeted therapy. Given the structural similarity of NALP3 to other NALPs, the possibility of involvement of the alternative, homologous genes cannot be eliminated.

京都大学 / 新制・論文博士 / 博士(医学) / 乙第13635号 / 論医博第2326号 / 新制||医||1074(附属図書館) / 京都大学大学院医学研究科医学専攻 / (主査)教授 齋藤 潤, 教授 森信 暁雄, 教授 松田 文彦 / 学位規則第4条第2項該当 / Doctor of Medical Science / Kyoto University / DFAM

Cisplatin, a platinum-based drug extensively utilized in chemotherapy, is effective in treating a variety of cancer forms. Clinical studies have shown that cisplatin triggers muscle wasting and dysfunction, which significantly impacts the clinical prognosis of cancer patients. Additionally, recent research revealed that pyroptosis, a highly inflammatory cell-death, mediates muscle wasting. However, its role in cisplatin-induced skeletal muscle toxicity remains unclear. Therefore, we hypothesized that cisplatin induces myotoxicity and causes adverse skeletal muscle remodeling through pyroptosis. In this study, C57BL/6 mice (10±2 weeks old) were divided into two groups: Control(saline) and Cisplatin (cisplatin). Saline and Cisplatin were respectively administered via intraperitoneal injection (i.p.) at 2.3mg/kg body weight (BW) for 5 consecutive days (first cycle), followed by 5 days of rest, and then another 5 consecutive days (second cycle), making it a total of 10 injections and a cumulative dose of 23 mg/kg BW. At day 29 (D29), the muscle function was assessed by subjecting the mice to grip force tests and weight tests. Gastrocnemius muscle tissues from sacrificed mice were collected for histological analysis. Further analysis for protein expression of pyroptosis-associated markers (TLR4, NLRP3, Caspase-1, IL-1β, IL-18, and GSDMD) was performed using immunohistochemistry and western blotting. The stimulation of TLR4 leads to the formation of the NLRP3 inflammasome which initiates the activation of Caspase-1, Il-1β and IL-18, along with the executioner of pyroptosis, GSDMD. Our data revealed that cisplatin-treatment significantly (P

L’asthme est une maladie inflammatoire chronique des voies aériennes. Chez les individus sensibles, l’inhalation d’allergènes entraine une inflammation pulmonaire se traduisant par des épisodes récurrents de toux, de difficultés respiratoires et une sécrétion de mucus. Des études réalisées chez l’animal ont mis en évidence un rôle crucial des lymphocytes Th2 et des cytokines associées (IL-4, IL-5 et IL-13). Plus récemment, il a été montré que les lymphocytes Th17 participaient à la physiopathologie de l’asthme. La présente étude s’intéresse à une cytokine majoritairement produite par les Th17 : l’IL-22. Différents travaux indiquent que cette cytokine serait impliquée dans l’immunitémucosale où elle exercerait des effets protecteurs ou pro-inflammatoires en fonction du modèle expérimental étudié. En utilisant un modèle murin d’inflammation pulmonaire allergique induite par l’ovalbumine, nous avons montré que l’IL-22 jouait un rôle pro-inflammatoire au cours de l’induction de l’asthme allergique puisque les souris déficientes en IL-22 développent une forme atténuée de la maladie. A l’inverse, nous avons constaté que l’IL-22 avait un effet protecteur dans la phase effectrice, et que cet effet était dépendant de l’IL-17A. Nos travaux mettent donc en lumière une double fonction de l’IL-22 dans l’asthme allergique chez la souris. En parallèle de ce travail, nous nous sommes intéressés au rôle de l’IL-1 et de l’inflammasome NLRP3 dans ce même modèle d’inflammation pulmonaire. Enfin, une troisième étude a permis de mettre en lumière un rôle encore inconnu de l’interleukine-33 dans l’activation des cellules dendritiques au cours de la mise en place de la réponse asthmatique. / Asthma is a heterogenous inflammatory disorder of the airways characterized by chronic airway inflammation, airway hyper-reactivity and by symptoms of recurrent wheezing, coughing and shortness breath. Understanding of the role of allergy and Th2 cells in asthma has benefited from mouse model of allergic asthma. Recently, several studies highlighted Th17 involvement in asthma pathogenesis. In the present study, we investigate the role of IL-22, a Th17-related cytokine, in a mouse model of allergic lung inflammation induced by ovalbumin. First, using IL-22 deficient mice, we demonstrated a pro-inflammatory role of IL-22 during the sensitization phase. In contrast, we observed a protective function of IL-22 during the effective phase. This protective effect of IL-22 seems to be dependent of IL-17. In conclusion, we demonstrate here a dual role of IL-22 in asthma pathogenesis. Since interleukin-1_ is critical for Th17 polarization in human, we also investigated the role of IL-1 signalling and NLRP3 inflammasome in our model of allergic airway inflammation. We showed that NLRP3 inflammasome and IL-1R/IL-1 pathway are critical to induce allergic lung inflammation, even in the absence of adjuvant. Finally, we studied the effect of interleukin-33 on dendritic cells activation and Th2 priming during antigen sensitization and in established asthma.

L'inflammasome est une voie de signalisation du système immunitaire inné impliquée dans la lutte contre les pathogènes et notamment dans la réponse aux infections bactérienne. L'activation de l'inflammasome entraine la sécrétion de cytokines pro-inflammatoires et une mort cellulaire caspase-1 dépendante. Des dérégulations de l'inflammasome conduisent aussi à des syndromes auto-inflammatoires graves ; il est donc essentiel de mieux comprendre sa régulation. Francisella tularensis est une bactérie intracellulaire facultative responsable de la tularémie. Son pouvoir pathogène est lié à sa capacité à s'échapper rapidement de son phagosome. Le système de surveillance du macrophage détecte la présence de F. tularensis via l'inflammasome AIM2. La détection de l'ADN bactérien induit la formation d'un large complexe composé de AIM2, le récepteur, d'ASC, l'adaptateur et de caspase-1, l'effecteur ; ce complexe forme un speck visible dans la cellule. Nous avons utilisé l'infection par F. tularensis de macrophages primaires murins pour étudier la régulation de l'inflammasome AIM2 dans un contexte physiologique. Nous avons ainsi identifié une boucle de rétrocontrôle, médiée par la caspase-1, qui régule négativement la formation/stabilité des specks AIM2. Nous avons étudié le rôle de facteurs vacuolaires et des espèces réactives de l'oxygène et de l'azote dans l'activation de l'inflammasome AIM2 lors de l'infection par Francisella. Nous avons ainsi mis en évidence le rôle clef des péroxynitrites dans cette activation. Nos résultats suggèrent que des décomposeurs catalytiques des péroxynitrites pourraient avoir un rôle thérapeutique dans les maladies liées à l'inflammasome / The inflammasome is an innate immune signaling pathway involved in the fight against pathogens. This pathway can also be activated by danger signals. Inflammasome activation induces the release of the pro-inflammatory cytokines IL-1b and IL-18 and cell death in a caspase-1 dependent manner. The inflammasome pathway is a key antibacterial pathway. Deregulation of the inflammasome pathway can lead to serious auto-inflammatory syndromes ; it is therefore critical to better understand inflammasome regulation. Francisella tularensis is a facultative intracellular bacterium responsible for tularemia. Its ability to cause disease is linked to its ability to rapidly escape from the phagosome into the host cytosol where it replicates. The macrophage surveillance system can detect F. tularensis presence in the cytosol through the AIM2 inflammasome. Recognition of DNA induces the formation of a large complex consisting of AIM2, the receptor; ASC, the adaptor and caspase-1, the effector; this complex is visible as a speck within the cell. We used F. tularensis infection of bone marrow derived macrophages to study the activation of the AIM2 inflammasome in a physiological context. We have identified a feedback loop, dependent on caspase-1, negatively regulating speck formation/stability. Then, we studied the role of vacuolar factors and reactive oxygen and nitrogen species in the AIM2 inflammasome activation during Francisella infection. We also described a key role for peroxynitrite in this activation. Our results suggest that catalytic decomposer of peroxynitrite may have a therapeutic potential in diseases linked to inflammasome

L'infarctus du myocarde est la première cause de mortalité dans le monde. La reperfusion précoce est le traitement central de la prise en charge thérapeutique. Mais bien que salvatrice, la reperfusion s'accompagne elle-même de lésion dite de reperfusion. La mitochondrie et l'ouverture du pore de transition de perméabilité mitochondriale (mPTP) sont au centre de ces lésions de reperfusion. Le dysfonctionnement mitochondrial et la nécrose entraine par ailleurs une intense réponse inflammatoire locale et systémique. Le post-conditionnement ischémique et pharmacologique (par la cyclosporine A, CsA) constitue une voie de recherche importante afin de limiter les lésions de reperfusion. Mes travaux de thèse se sont attachés à étudier le rôle de la Sirtuine 3 dans la cardioprotection ainsi que d'étudier la réponse inflammatoire locale et systémique induite par l'ischémie/reperfusion (I/R) myocardique.Nous avons précisé le mécanisme d'action du post-conditionnement, qui semble médié par l'activation de la sirtuine 3 et la désacétylation de la cyclophiline D qui contribue à inhiber l'ouverture du mPTP. Nous avons ensuite montré que l'I/R myocardique induisait une intense réponse inflammatoire chez l'homme avec un rôle particulier d'IL-17A, IL-6, IL-8 et IL-10. Cependant, cette réponse inflammatoire n'était pas modifiée par l'utilisation de CsA. Enfin, nous avons pu montrer que le facteur induit par l'hypoxie (HIF-1a), qui est surexprimé lors de l'I/R est un important activateur la réponse inflammatoire, notamment sur l'inflammasome, et que le Nicotinamide Mononucléotide possède un rôle anti-inflammatoire en empêchant la stabilisation de HIF-1a. Tous ces éléments sont autant de cibles thérapeutiques potentielles à développer avec de nouvelles études / Myocardial infarction (MI) is the first cause of death in the world. Reperfusion is the key treatment of MI. However, reperfusion can cause reperfusion injuries. Mitochondria and mitochondrial permeablility transition pore are the target of reperfusion injuries. Mitochondrial dysfonction and necrosis lead to an intense local and systemic inflammation. Ischemic post-conditioning (PC) and pharmacologic PC (with cyclosporine A, CsA) are used to limit reperfusion injuries. During my thesis, I worked on cardioprotective effet of sirtuin 3 and I studied inflammation induced by myocardial ischemia/reperfusion (I/R). I have shown that ischemic PC involve sirtuin 3 and deacetylation of cyclophilin D. I demonstrated that myocardial I/R induce an intense inflammatory response in Human with a key role of IL-17A, IL-6, IL-8 and IL-10. However, this inflammatory response is not modulated by the administration of CsA. A least, we studied the role of HIF-1a that is over expressed during I/R. We showed that HIF-1a activate inflammasome and the secretion of IL-1beta and IL-18. Furthermore, Nicotinamied Mononucleotide has anti-inflammatory effets with an action of HIF-1a. Taken together, these data contribute to develop new target for cardioprotection